Wednesday, December 2nd | 16 Kislev 5781

Subscribe
July 27, 2015 9:33 am

Israel’s Teva Pharmaceuticals to Purchase Allegran Generics for $40.5 Billion

avatar by News Editor

Israel's Teva will acquire Allergan for $40.5 billion. Photo: Screenshot.

Israel’s Teva pharmaceuticals will acquire Allergan for $40.5 billion. Photo: Screenshot.

Allergan President and CEO Brent Saunders said Monday the sale of its generics business would allow the company to double down on its higher margin, higher growth branded drugs business.

Saunders spoke on CNBC’s Squawk Box after Israel’s Teva Pharmaceutical announced plans to purchase Dublin-based Allergan’s generic pharmaceuticals business for $40.5 billion.

Read full story at CNBC.

Share this Story: Share On Facebook Share On Twitter

Let your voice be heard!

Join the Algemeiner

Algemeiner.com

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.